Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Debt Ratio (2024 - 2025)

Historic Debt Ratio for Apellis Pharmaceuticals (APLS) over the last 2 years, with Q3 2025 value amounting to 0.43.

  • Apellis Pharmaceuticals' Debt Ratio rose 789.1% to 0.43 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43, marking a year-over-year increase of 789.1%. This contributed to the annual value of 0.41 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Apellis Pharmaceuticals' Debt Ratio is 0.43, which was up 789.1% from 0.44 recorded in Q2 2025.
  • Over the past 5 years, Apellis Pharmaceuticals' Debt Ratio peaked at 0.45 during Q1 2025, and registered a low of 0.4 during Q3 2024.